Stay up to date with the latest clinical business news in the industry!

  • Datasheet: Global Secondary Packaging Capabilities
    Aptuit offers a comprehensive suite of drug development services that range from candidate selection through to market, including consultancy services, API development and manufacture, preclinical and clinical technologies, pharmaceutical services, large and small scale manufacturing, IVRS, and clinical packaging and logistics, across a wide range of compounds, dosage forms and ... read more
    Source: Clinical LeaderPublished on 2019-08-25
    9 hours ago
  • Datasheet: QT Prolongation Risk Assessment
    The ICHS7B and E14 documents provide guidance on the assessment of risk of QT prolongation and cardiac arrhythmias by compounds undergoing preclinical and clinical development. ... read more
    Source: Clinical LeaderPublished on 2019-08-25
    9 hours ago
  • Fact Sheet: Clinical Packaging And Logistics
    Aptuit understands the importance of clinical packing and logistics in the drug development continuum. Our experienced and innovative team offers integrated solutions, ensuring that our services not only stand alone, but also fit seamlessly into your drug development program. ... read more
    Source: Clinical LeaderPublished on 2019-08-25
    9 hours ago
  • Product Catalog: Wallet Technology
    The Wallet package is a marketing instrument. More and more, pharmaceutical companies follow the growing trend and package their tablet blisters in Wallet packs. ... read more
    Source: Clinical LeaderPublished on 2019-08-25
    9 hours ago
  • Datasheet: Regulatory Strategy/Submissions Services
    Regulatory Affairs is a key area of pharmaceutical consulting which touches all other disciplines (eg, chemistry, manufacturing, and controls; preclinical; and clinical). Knowledgeable in the FDA, HPFB, and EMEA regulatory requirements for clinical testing and marketing approval and serving as a conduit to regulatory authorities, Aptuit Consulting provides a cohesiveness ... read more
    Source: Clinical LeaderPublished on 2019-08-25
    9 hours ago
  • A model summer: Preclinical research developments rise with the temperature
    As summer heated up, the pharmaceutical industry saw major developments in preclinical models from new software to 3D-printed tissue, all in the name of drug development. ... read more
    Source: Outsourced PharmaPublished on 2019-08-23
    3 days ago
  • Applications in Pharmaceutical Manufacturing
    ... read more
    Source: Applied Clinical Trials OnlinePublished on 2019-08-23By Applied Clinical Trials
    3 days ago
  • AstraZeneca Announces Positive Results from Farxiga Phase III Trial
    In an Aug. 20, 2019 press release, AstraZeneca announced that its therapy for the treatment of patients with heart failure, Farxiga (dapagliflozin), has met the primary endpoint, according to results of the Phase III Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) tri ... read more
    Source: Applied Clinical Trials OnlinePublished on 2019-08-22By Applied Clinical Trials
    3 days ago
  • Analysis Shows that EU and US are Highly Aligned for Marketing Decisions
    Joint analysis from the European Medicines Agency and the US Food and Drug Administration (FDA) has shown that the regulatory bodies are highly aligned in the majority of marketing authorization decisions. In an Aug. 16, 2019 press release, EMA highlighted the alignment finding from the jo ... read more
    Source: Applied Clinical Trials OnlinePublished on 2019-08-22By Applied Clinical Trials
    3 days ago
  • Applications in Pharmaceutical Manufacturing
    Sponsored Content - EU This application describes the analysis of complex peptones. Excellent chromatographic performance was achieved using 2D-LC with active solvent modulation. ... read more
    Source: Applied Clinical Trials OnlinePublished on 2019-08-22By Applied Clinical Trials
    3 days ago
1 2 3